BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Estcourt LJ, Cohn CS, Pagano MB, Iannizzi C, Kreuzberger N, Skoetz N, Allen ES, Bloch EM, Beaudoin G, Casadevall A, Devine DV, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Grossman BJ, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Tobian AAR. Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma. Ann Intern Med 2022. [PMID: 35969859 DOI: 10.7326/M22-1079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kiss-dala N, Szabo BG, Lakatos B, Reti M, Szlavik J, Valyi-nagy I. Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary. GeroScience 2022. [DOI: 10.1007/s11357-022-00683-4] [Reference Citation Analysis]
2 Bloch EM, Sullivan DJ, Shoham S, Tobian AAR, Casadevall A, Gebo KA. The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox. mBio 2022. [DOI: 10.1128/mbio.02862-22] [Reference Citation Analysis]
3 Baker JV, Lane HC. The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma. Ann Intern Med 2022. [PMID: 35969864 DOI: 10.7326/M22-2329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]